SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Keryx Biopharmaceuticals, Inc.
(NASDAQ : KERX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading KERX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.79%86.551.6%$778.69m
BIIBBiogen Inc.
1.89%287.781.2%$583.61m
CELGCelgene Corporation
0.07%107.521.1%$489.51m
AMGNAmgen Inc.
0.90%165.671.2%$488.57m
REGNRegeneron Pharmaceuticals, Inc.
0.47%391.343.1%$323.98m
ALXNAlexion Pharmaceuticals, Inc.
-1.18%125.802.6%$289.82m
TSROTESARO, Inc.
-0.05%91.9918.0%$215.68m
BMRNBioMarin Pharmaceutical Inc.
0.24%93.583.9%$197.30m
ILMNIllumina, Inc.
-0.36%150.765.1%$188.17m
MDVNMedivation, Inc.
0.14%62.632.6%$145.51m
VRTXVertex Pharmaceuticals Incorporated
0.73%93.891.7%$132.65m
JUNOJuno Therapeutics, Inc.
1.04%29.137.9%$106.11m
AAgilent Technologies, Inc.
-0.21%46.571.9%$100.85m
INCYIncyte Corporation
-1.57%86.412.2%$87.30m
ACADACADIA Pharmaceuticals Inc.
1.36%36.5513.1%$79.16m

Company Profile

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.